Dr. Gregory Clark Discusses Leptin Study at JDRF Research Update Meeting
On Thursday, January 20, 2011, Dr. Gregory Clark, an Endocrinologist and Assistant Professor at UT-Southwestern, gave a wonderful presentation at our Winter Research Update and Open Board Meeting on the research study investigating Metreleptin as a potential therapy to improve blood glucose control in type 1 diabetes.
JDRF and Amylin Pharmaceuticals, Inc. have partnered together in a research collaboration agreement to provide financial support for this this clinical proof-of-concept study that is being conducted at UT-Southwestern Medical Center with Dr. Roger Unger, Dr. Abhimanyu Garg and Dr. Gregory Clark. Read more about this diabetes research.
View video of Dr. Clark’s presentation below (2 parts):
.
You can also view his PowerPoint Presentation.
A special thank you goes to Dr. Clark, who also serves on the JDRF Greater Dallas Chapter Board of Directors, for sharing his time and talents with JDRF. We greatly appreciate his dedication and support in advancing important diabetes research.
We host regular Research Updates and Open Board Meetings throughout the year, please be sure and mark your calendar for our Annual Meeting Research Update taking place on Thursday, June 16. If you are interested in attending, please contact Julie Brown at (214) 373-9808 or jabrown@jdrf.org. We hope to see you there!
To learn more about the JDRF Dallas chapter, visit our JDRF Dallas website!
jdrfdallas.wordpress.com 
I have a son in college in Austin and a sister in Tucson, Arizona, both with type 1 diabetes. Are the study candidates required to live locally in Dallas?
Thank you Sanju for your comment and interest. Due to the amount of visits and hospital stays required for this study, the participants should live in the DFW area. If your son and sister are interested in participating in clinical trials, please have them visit JDRF’s Type 1 Diabetes Clinical Trials Connection at https://trials.jdrf.org/patient/index.cfm. The goal of this free registry is to simplify the process of finding trials that may be of interest to them by providing information on the latest research advances, new research studies, and information about opportunities to participate in clinical trials. Participating in a clinical trial is an important way for people to help to find a cure for type 1 diabetes and its complications. That’s particularly true today, when JDRF’s nearly 40 years of research leadership has brought us to the point where scientific advances made in the laboratory are being tested in people. Thanks again for your interest!